With over five decades of trust, Alkem Laboratories has built a formidable presence as one of India’s leading pharmaceutical companies, operating across 40+ countries. From a single manufacturing unit, it has grown into the fifth-largest player in the domestic market, with leadership in acute therapies and iconic brands such as Clavam, Pan, Pan-D and Taxim-O. India remains its strategic anchor, while international markets are a key pillar of growth, supported by subsidiaries and parent-led operations. Consolidated revenue stood at ₹1,29,645 million reflecting strong execution and a globally scalable business model.